Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors.

about

What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?Developing more effective, non-neurotoxic, methotrexate-based therapy in infants with brain tumors.Reply to Prof Ian J. Cohen.

P2860

Q30397448-759C6D44-F1AD-4AA2-AA61-182A7DC41280 Q48716763-10DE6508-53C9-41D0-A48D-4E39E50775D2 Q50858392-D98F871E-57A4-48E1-9361-76C9F022872D

P2860

Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors.

Item

http://www.wikidata.org/entity/Q39911676

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pharmacokinetics of high-dose ...... d for aggressive brain tumors.

@en

Pharmacokinetics of high-dose ...... d for aggressive brain tumors.

@nl

type

Item

label

Pharmacokinetics of high-dose ...... d for aggressive brain tumors.

@en

Pharmacokinetics of high-dose ...... d for aggressive brain tumors.

@nl

prefLabel

Pharmacokinetics of high-dose ...... d for aggressive brain tumors.

@en

Pharmacokinetics of high-dose ...... d for aggressive brain tumors.

@nl

P1476

Pharmacokinetics of high-dose ...... ed for aggressive brain tumors

@en

P2093

Claudio Favre

http://www.w3.org/2001/XMLSchema#string

Maurizio de Martino

http://www.w3.org/2001/XMLSchema#string

Patrizio Fiorini

http://www.w3.org/2001/XMLSchema#string

Silvia Farina

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.

7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.

Understanding and managing methotrexate nephrotoxicity.

Current treatment approaches for infants with malignant central nervous system tumors.

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Remission induction of meningeal leukemia with high-dose intravenous methotrexate.

Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia.

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.

P2888

s00280-016-3008-8

P304

857-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-016-3008-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26988222

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors.

about

P2860

P2860

Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698